KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Cash from Investing Activities (2017 - 2025)

Historic Cash from Investing Activities for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to -$4.7 million.

  • Bionano Genomics' Cash from Investing Activities rose 1313.49% to -$4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.8 million, marking a year-over-year decrease of 18894.56%. This contributed to the annual value of $73.8 million for FY2024, which is 20565.03% up from last year.
  • Latest data reveals that Bionano Genomics reported Cash from Investing Activities of -$4.7 million as of Q3 2025, which was up 1313.49% from $2.0 million recorded in Q2 2025.
  • In the past 5 years, Bionano Genomics' Cash from Investing Activities registered a high of $47.6 million during Q1 2024, and its lowest value of -$185.6 million during Q3 2021.
  • Moreover, its 5-year median value for Cash from Investing Activities was $3.0 million (2024), whereas its average is -$6.0 million.
  • Per our database at Business Quant, Bionano Genomics' Cash from Investing Activities crashed by 747559.18% in 2021 and then skyrocketed by 13328333.33% in 2022.
  • Over the past 5 years, Bionano Genomics' Cash from Investing Activities (Quarter) stood at -$92.5 million in 2021, then soared by 112.55% to $11.6 million in 2022, then crashed by 576.94% to -$55.4 million in 2023, then skyrocketed by 105.41% to $3.0 million in 2024, then crashed by 255.79% to -$4.7 million in 2025.
  • Its Cash from Investing Activities stands at -$4.7 million for Q3 2025, versus $2.0 million for Q2 2025 and -$14.1 million for Q1 2025.